Katharina Margherita Wakonig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Katharina Margherita Wakonig has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Markus Herbert Lerchbaumer
Charité—University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Radiology, Charitéplatz 1, 10117 Berlin, Germany
5 shared publications - Philipp Arens
Department of Otorhinolaryngology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Campus Virchow Klinikum and Campus Charité Mitte, Charitéplatz 1, 10117 Berlin, Germany
4 shared publications - Steffen Dommerich
Charité—University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Otorhinolaryngology, Charitéplatz 1, 10117 Berlin, Germany
4 shared publications - Thomas Fischer
Department of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany
4 shared publications - Heidi Olze
Department of Otorhinolaryngology, Head and Neck Surgery, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117 Berlin, Germany
3 shared publications - Bernd Hamm
European Radiology, European Society of Radiology, Vienna, Austria
2 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (19) , 3115
Diagnostic Accuracy of Multiparametric Ultrasound Versus Cross-Sectional Imaging for Differentiating Benign and Malignant Cervical Lymph Nodes: A Histopathology-Referenced Retrospective Study
Background/Objectives: Accurate differentiation between benign and malignant cervical lymphadenopathy is a central task in head and neck imaging. This distinction is relevant in oncologic follow-up and in the general evaluation of enlarged cervical lymph nodes (CLNs), as nodal status influences prognosis, further diagnostic work-up, and treatment planning, including invasive diagnostic procedures or surgery. Current cross-sectional imaging approaches show variable diagnostic performance. This study aimed to compare the diagnostic accuracy of multiparametric ultrasound (mpUS) and cross-sectional imaging for the differentiation of benign and malignant CLNs. Methods: Data from a consecutive series of patients who underwent mpUS examination of a CLN, including B-mode, color-coded duplex sonography (CCDS), shear-wave elastography (SWE) and contrast-enhanced ultrasonography (CEUS) were retrospectively analyzed at the lymph-node level. Patients were eligible if complete mpUS and cross-sectional imaging documentation before tissue sampling was available. Histopathologic reports served as the reference standard. Accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were analyzed. Results: A total of 97 CLNs from 92 patients were analyzed; 33 CLNs were benign. Compared with cross-sectional imaging, mpUS showed higher accuracy by 15.5% (95% CI, 6.0–24.9%), higher sensitivity by 12.5% (95% CI, 2.5–23.4%), with higher PPV and NPV. In the exploratory analysis, CEUS and SWE improved the discriminatory power of B-mode and CCDS, with the complete mpUS protocol providing the best overall discrimination. Conclusions: MpUS showed higher accuracy, sensitivity, PPV and NPV than cross-sectional imaging. These findings suggest that mpUS may help characterize enlarged CLNs during diagnostic work-up and oncologic follow-up.
- 25 September 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (19) , 3115
Open AccessDiagnostic Accuracy of Multiparametric Ultrasound Versus Cross-Sectional Imaging for Differentiating Benign and Malignant Cervical Lymph Nodes: A Histopathology-Referenced Retrospective Study
Background/Objectives: Accurate differentiation between benign and malignant cervical lymphadenopathy is a central task in head and neck imaging. This distinction is relevant in oncologic follow-up and in the general evaluation of enlarged cervical lymph nodes (CLNs), as nodal status influences prognosis, further diagnostic work-up, and treatment planning, including invasive diagnostic procedures or surgery. Current cross-sectional imaging approaches show variable diagnostic performance. This study aimed to compare the diagnostic accuracy of multiparametric ultrasound (mpUS) and cross-sectional imaging for the differentiation of benign and malignant CLNs. Methods: Data from a consecutive series of patients who underwent mpUS examination of a CLN, including B-mode, color-coded duplex sonography (CCDS), shear-wave elastography (SWE) and contrast-enhanced ultrasonography (CEUS) were retrospectively analyzed at the lymph-node level. Patients were eligible if complete mpUS and cross-sectional imaging documentation before tissue sampling was available. Histopathologic reports served as the reference standard. Accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were analyzed. Results: A total of 97 CLNs from 92 patients were analyzed; 33 CLNs were benign. Compared with cross-sectional imaging, mpUS showed higher accuracy by 15.5% (95% CI, 6.0–24.9%), higher sensitivity by 12.5% (95% CI, 2.5–23.4%), with higher PPV and NPV. In the exploratory analysis, CEUS and SWE improved the discriminatory power of B-mode and CCDS, with the complete mpUS protocol providing the best overall discrimination. Conclusions: MpUS showed higher accuracy, sensitivity, PPV and NPV than cross-sectional imaging. These findings suggest that mpUS may help characterize enlarged CLNs during diagnostic work-up and oncologic follow-up.
- Open Access
- 6 September 2025
- Published by Wiley in Head & Neck
- Vol. 48 (2) , 392-406
Multiparametric Ultrasound for Preoperative Assessment of Parotid Tumors: A Novel Diagnostic Pathway
Background: Accurate preoperative differentiation of parotid gland tumors (PGTs) is essential for facial nerve preservation. This study evaluates a novel, real‐time multiparametric ultrasound (mpUS) approach combining B‐mode, shear wave elastography (SWE), and contrast‐enhanced ultrasound (CEUS), based on qualitative image interpretation. Methods: Eighty‐nine patients with 91 PGTs underwent mpUS prior to surgery or ultrasound‐guided biopsy. Two blinded experts independently reviewed the images and reached consensus through real‐time discussion. Only qualitative features were assessed. Histopathology served as the reference. Results: mpUS achieved 83% sensitivity (95% CI: 62.6–94.0), 94% specificity (95% CI: 84.3–98.1), and 91% accuracy (95% CI: 82.4–96.3). CEUS and SWE provided complementary perfusion and stiffness data. CCDS was excluded due to limited value. Conclusion: mpUS improves diagnostic accuracy compared to single‐modality US and supports early, targeted treatment. Limitations include the small number of malignancies, single‐center design, and qualitative evaluation. Broader use may require training and equipment access.
- 6 September 2025
- Published by Wiley in Head & Neck
- Vol. 48 (2) , 392-406
Open AccessMultiparametric Ultrasound for Preoperative Assessment of Parotid Tumors: A Novel Diagnostic Pathway
Background: Accurate preoperative differentiation of parotid gland tumors (PGTs) is essential for facial nerve preservation. This study evaluates a novel, real‐time multiparametric ultrasound (mpUS) approach combining B‐mode, shear wave elastography (SWE), and contrast‐enhanced ultrasound (CEUS), based on qualitative image interpretation. Methods: Eighty‐nine patients with 91 PGTs underwent mpUS prior to surgery or ultrasound‐guided biopsy. Two blinded experts independently reviewed the images and reached consensus through real‐time discussion. Only qualitative features were assessed. Histopathology served as the reference. Results: mpUS achieved 83% sensitivity (95% CI: 62.6–94.0), 94% specificity (95% CI: 84.3–98.1), and 91% accuracy (95% CI: 82.4–96.3). CEUS and SWE provided complementary perfusion and stiffness data. CCDS was excluded due to limited value. Conclusion: mpUS improves diagnostic accuracy compared to single‐modality US and supports early, targeted treatment. Limitations include the small number of malignancies, single‐center design, and qualitative evaluation. Broader use may require training and equipment access.
- Open Access
- 6 March 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (5) , 635
Comparing ChatGPT 4.0’s Performance in Interpreting Thyroid Nodule Ultrasound Reports Using ACR-TI-RADS 2017: Analysis Across Different Levels of Ultrasound User Experience
Background/Objectives: This study evaluates ChatGPT 4.0’s ability to interpret thyroid ultrasound (US) reports using ACR-TI-RADS 2017 criteria, comparing its performance with different levels of US users. Methods: A team of medical experts, an inexperienced US user, and ChatGPT 4.0 analyzed 100 fictitious thyroid US reports. ChatGPT’s performance was assessed for accuracy, consistency, and diagnostic recommendations, including fine-needle aspirations (FNA) and follow-ups. Results: ChatGPT demonstrated substantial agreement with experts in assessing echogenic foci, but inconsistencies in other criteria, such as composition and margins, were evident in both its analyses. Interrater reliability between ChatGPT and experts ranged from moderate to almost perfect, reflecting AI’s potential but also its limitations in achieving expert-level interpretations. The inexperienced US user outperformed ChatGPT with a nearly perfect agreement with the experts, highlighting the critical role of traditional medical training in standardized risk stratification tools such as TI-RADS. Conclusions: ChatGPT showed high specificity in recommending FNAs but lower sensitivity and specificity for follow-ups compared to the medical student. These findings emphasize ChatGPT’s potential as a supportive diagnostic tool rather than a replacement for human expertise. Enhancing AI algorithms and training could improve ChatGPT’s clinical utility, enabling better support for clinicians in managing thyroid nodules and improving patient care. This study highlights both the promise and current limitations of AI in medical diagnostics, advocating for its refinement and integration into clinical workflows. However, it emphasizes that traditional clinical training must not be compromised, as it is essential for identifying and correcting AI-driven errors.
- 6 March 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (5) , 635
Open AccessComparing ChatGPT 4.0’s Performance in Interpreting Thyroid Nodule Ultrasound Reports Using ACR-TI-RADS 2017: Analysis Across Different Levels of Ultrasound User Experience
Background/Objectives: This study evaluates ChatGPT 4.0’s ability to interpret thyroid ultrasound (US) reports using ACR-TI-RADS 2017 criteria, comparing its performance with different levels of US users. Methods: A team of medical experts, an inexperienced US user, and ChatGPT 4.0 analyzed 100 fictitious thyroid US reports. ChatGPT’s performance was assessed for accuracy, consistency, and diagnostic recommendations, including fine-needle aspirations (FNA) and follow-ups. Results: ChatGPT demonstrated substantial agreement with experts in assessing echogenic foci, but inconsistencies in other criteria, such as composition and margins, were evident in both its analyses. Interrater reliability between ChatGPT and experts ranged from moderate to almost perfect, reflecting AI’s potential but also its limitations in achieving expert-level interpretations. The inexperienced US user outperformed ChatGPT with a nearly perfect agreement with the experts, highlighting the critical role of traditional medical training in standardized risk stratification tools such as TI-RADS. Conclusions: ChatGPT showed high specificity in recommending FNAs but lower sensitivity and specificity for follow-ups compared to the medical student. These findings emphasize ChatGPT’s potential as a supportive diagnostic tool rather than a replacement for human expertise. Enhancing AI algorithms and training could improve ChatGPT’s clinical utility, enabling better support for clinicians in managing thyroid nodules and improving patient care. This study highlights both the promise and current limitations of AI in medical diagnostics, advocating for its refinement and integration into clinical workflows. However, it emphasizes that traditional clinical training must not be compromised, as it is essential for identifying and correcting AI-driven errors.
- Open Access
The Diagnostic Performance of Multiparametric Ultrasound in the Qualitative Assessment of Inconclusive Cervical Lymph Nodes
Background: Enlarged cervical lymph nodes (CLNs) can result from infection or malignancies, and a definitive diagnosis requires histological examination. Ultrasound (US) remains the first-line imaging modality for detection, and new US techniques may improve characterization. The aim of our study was to investigate whether the qualitative assessment of multiparametric US (mpUS) can improve diagnostic performance in the differentiation of benign and malignant CLNs. Methods: 107 CLNs in 105 patients were examined by preoperative mpUS consisting of B-mode US, color-coded duplex sonography (CCDS), shear wave elastography (SWE) and contrast-enhanced US (CEUS). US images were evaluated in consensus by two experienced US operators. Histopathological examination was used as reference standard. Results: SWE and CEUS combined showed the highest overall diagnostic performance (91% sensitivity, 77% specificity, 87% positive predictive value (PPV), 83% negative predictive value (NPV), 90% accuracy, χ2 (1) = 51.485, p < 0.001) compared to B-mode US and CCDS (87% sensitivity, 44% specificity, 73% PPV, 65% NPV, 73% accuracy χ2 (1) = 12.415, p < 0.001). In terms of individual techniques, SWE had higher specificity than B-mode and CCDS (71% sensitivity, 90% specificity, 92% PPV, 64% NPV, 78% accuracy, χ2 (1) = 36.115, p < 0.001), while qualitative CEUS showed the best diagnostic performance of all investigated US techniques (93% sensitivity, 85% specificity, 91% PPV, 87% NPV, 90% accuracy, χ2 (1) = 13.219, p < 0.001). Perfusion patterns, homogeneity, presence of necrosis, and malignancy differed significantly between malignant and benign CLNs (p < 0.001). Conclusions: SWE and CEUS can facilitate the differentiation of inconclusive CLNs when performed to supplement B-mode US and CCDS. MpUS may thus aid the decision between surgery and a watch-and-scan strategy in enlarged CLNs.
Open AccessThe Diagnostic Performance of Multiparametric Ultrasound in the Qualitative Assessment of Inconclusive Cervical Lymph Nodes
Background: Enlarged cervical lymph nodes (CLNs) can result from infection or malignancies, and a definitive diagnosis requires histological examination. Ultrasound (US) remains the first-line imaging modality for detection, and new US techniques may improve characterization. The aim of our study was to investigate whether the qualitative assessment of multiparametric US (mpUS) can improve diagnostic performance in the differentiation of benign and malignant CLNs. Methods: 107 CLNs in 105 patients were examined by preoperative mpUS consisting of B-mode US, color-coded duplex sonography (CCDS), shear wave elastography (SWE) and contrast-enhanced US (CEUS). US images were evaluated in consensus by two experienced US operators. Histopathological examination was used as reference standard. Results: SWE and CEUS combined showed the highest overall diagnostic performance (91% sensitivity, 77% specificity, 87% positive predictive value (PPV), 83% negative predictive value (NPV), 90% accuracy, χ2 (1) = 51.485, p < 0.001) compared to B-mode US and CCDS (87% sensitivity, 44% specificity, 73% PPV, 65% NPV, 73% accuracy χ2 (1) = 12.415, p < 0.001). In terms of individual techniques, SWE had higher specificity than B-mode and CCDS (71% sensitivity, 90% specificity, 92% PPV, 64% NPV, 78% accuracy, χ2 (1) = 36.115, p < 0.001), while qualitative CEUS showed the best diagnostic performance of all investigated US techniques (93% sensitivity, 85% specificity, 91% PPV, 87% NPV, 90% accuracy, χ2 (1) = 13.219, p < 0.001). Perfusion patterns, homogeneity, presence of necrosis, and malignancy differed significantly between malignant and benign CLNs (p < 0.001). Conclusions: SWE and CEUS can facilitate the differentiation of inconclusive CLNs when performed to supplement B-mode US and CCDS. MpUS may thus aid the decision between surgery and a watch-and-scan strategy in enlarged CLNs.
- Open Access
- 21 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 13 (1) , 12
Assessment of Parotid Gland Tumors by Means of Quantitative Multiparametric Ultrasound (mpUS)
Objective: The preoperative diagnostical differentiation of parotid gland tumor (PGT) is not always simple due to several different entities. B-mode-ultrasound (US) remains the imaging modality of choice, while histopathology serves as the gold standard for finalizing the diagnosis. We aimed to evaluate the use of multiparametric US (mpUS) in the assessment of PGT. Methods: We included 97 PGTs from 96 patients. A standardized mpUS protocol using B-mode-US, shear-wave elastography (SWE), and standardized contrast-enhanced ultrasound (CEUS) was performed prior to surgical intervention. SWE was assessed by real-time measurement conducting a minimum of five measurements, while quantitative CEUS parameters were assessed with a post-processing perfusion software. Results: SWE allowed differentiation between benign PGT (Warthin’s Tumor (WT) paired with lymph nodes (LN) and pleomorphic adenoma (PA)), and WT and LN were softer compared to PA. WT showed lower velocities than squamous cell carcinoma (SCC): the most common malignant PGT. CEUS parameters showed significant group differences between WT and PA, WT and malignant lesions, WT and SCC, WT paired with LN versus PA, and WT paired with LN versus SCC. Conclusion: MpUS seems to be beneficial in the assessment of PGT characterization, with benign PGT appearing to be softer in SWE than tumors with malignant tendencies. The quantitative CEUS parameter shows higher perfusion in WT than in PA, and malignant PGTs are less vascularized than WTs.
- 21 December 2022
- Published by MDPI AG in Diagnostics
- Vol. 13 (1) , 12
Open AccessAssessment of Parotid Gland Tumors by Means of Quantitative Multiparametric Ultrasound (mpUS)
Objective: The preoperative diagnostical differentiation of parotid gland tumor (PGT) is not always simple due to several different entities. B-mode-ultrasound (US) remains the imaging modality of choice, while histopathology serves as the gold standard for finalizing the diagnosis. We aimed to evaluate the use of multiparametric US (mpUS) in the assessment of PGT. Methods: We included 97 PGTs from 96 patients. A standardized mpUS protocol using B-mode-US, shear-wave elastography (SWE), and standardized contrast-enhanced ultrasound (CEUS) was performed prior to surgical intervention. SWE was assessed by real-time measurement conducting a minimum of five measurements, while quantitative CEUS parameters were assessed with a post-processing perfusion software. Results: SWE allowed differentiation between benign PGT (Warthin’s Tumor (WT) paired with lymph nodes (LN) and pleomorphic adenoma (PA)), and WT and LN were softer compared to PA. WT showed lower velocities than squamous cell carcinoma (SCC): the most common malignant PGT. CEUS parameters showed significant group differences between WT and PA, WT and malignant lesions, WT and SCC, WT paired with LN versus PA, and WT paired with LN versus SCC. Conclusion: MpUS seems to be beneficial in the assessment of PGT characterization, with benign PGT appearing to be softer in SWE than tumors with malignant tendencies. The quantitative CEUS parameter shows higher perfusion in WT than in PA, and malignant PGTs are less vascularized than WTs.
- Open Access
Quantitative Multiparametric Ultrasound (mpUS) in the Assessment of Inconclusive Cervical Lymph Nodes
Background: Enlarged cervical lymph nodes (CLN) are preferably examined by ultrasound (US) by using criteria such as size and echogenicity to assess benign and suspicious CLN, which should be histologically evaluated. This study aims to assess the differentiation of malign and benign CLN by using multiparametric US applications (mpUS). Methods: 101 patients received a standardized US protocol prior to surgical intervention using B-mode–US, shear-wave elastography (SWE) and contrast-enhanced ultrasound (CEUS). SWE was assessed by 2D real-time SWE conducting a minimum of five measurements, CEUS parameters were assessed with post-processing perfusion software. Histopathological confirmation served as the gold standard. Results: B-mode–US and SWE analysis of 104 CLN (36 benign, 68 malignant) showed a significant difference between benign and malignant lesions, presenting a larger long axis and higher tissue stiffness (both p < 0.001). Moreover, tissue stiffness assessed by SWE was significantly higher in CLN with regular B-mode–US criteria (Solbiati Index > 2 and short-axis < 1 cm, p < 0.001). No perfusion parameter on CEUS showed a significant differentiation between benign and malignant CLN. Discussion: As the only multiparametric parameter, SWE showed higher tissue stiffness in malignant CLN, also in subgroups with regular B-mode criteria. This fast and easy application may be a promising noninvasive tool to US examination to ameliorate the sonographic differentiation of inconclusive CLN.
Open AccessQuantitative Multiparametric Ultrasound (mpUS) in the Assessment of Inconclusive Cervical Lymph Nodes
Background: Enlarged cervical lymph nodes (CLN) are preferably examined by ultrasound (US) by using criteria such as size and echogenicity to assess benign and suspicious CLN, which should be histologically evaluated. This study aims to assess the differentiation of malign and benign CLN by using multiparametric US applications (mpUS). Methods: 101 patients received a standardized US protocol prior to surgical intervention using B-mode–US, shear-wave elastography (SWE) and contrast-enhanced ultrasound (CEUS). SWE was assessed by 2D real-time SWE conducting a minimum of five measurements, CEUS parameters were assessed with post-processing perfusion software. Histopathological confirmation served as the gold standard. Results: B-mode–US and SWE analysis of 104 CLN (36 benign, 68 malignant) showed a significant difference between benign and malignant lesions, presenting a larger long axis and higher tissue stiffness (both p < 0.001). Moreover, tissue stiffness assessed by SWE was significantly higher in CLN with regular B-mode–US criteria (Solbiati Index > 2 and short-axis < 1 cm, p < 0.001). No perfusion parameter on CEUS showed a significant differentiation between benign and malignant CLN. Discussion: As the only multiparametric parameter, SWE showed higher tissue stiffness in malignant CLN, also in subgroups with regular B-mode criteria. This fast and easy application may be a promising noninvasive tool to US examination to ameliorate the sonographic differentiation of inconclusive CLN.
- Open Access
- 31 October 2015
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 12 (1) , 1-12
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis
Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) have a similar clinical phenotype but represent distinct diseases, requiring different therapies. MicroRNAs (miRNAs) are short non-coding RNAs whose expression profiles can serve as diagnostic biomarkers and which may be involved in the pathophysiology of neuroinflammatory diseases. Here, we analyzed miRNA profiles in serum and whole blood of patients with NMOSD and clinically isolated syndrome (CIS)/relapsing-remitting MS (RRMS) as well as healthy controls by next-generation sequencing (NGS). MiRNA expression profiles were determined by NGS in sera of patients with aquaporin-4 antibody-positive NMOSD (n = 20), CIS/RRMS (n = 20), and healthy controls (n = 20) and in whole blood of patients with NMOSD (n = 11), CIS/RRMS (n = 60), and healthy controls (n = 43). Differentially expressed miRNAs were calculated by analysis of variance and t tests. All significance values were corrected for multiple testing. Selected miRNAs were validated in whole blood of patients with NMOSD (n = 18) and CIS/RRMS (n = 19) by quantitative real-time polymerase chain reaction (qRT-PCR). None of 261 miRNAs detected in serum but 178 of 416 miRNAs detected in whole blood showed significantly different expression levels among the three groups. Pairwise comparisons revealed 115 (NMOSD vs. CIS/RRMS), 141 (NMOSD vs. healthy controls), and 44 (CIS/RRMS vs. healthy controls) miRNAs in whole blood with significantly different expression levels. qRT-PCR confirmed different expression levels in whole blood of patients with NMOSD and CIS/RRMS for 9 out of 10 exemplarily chosen miRNAs. In silico enrichment analysis demonstrated an accumulation of altered miRNAs in NMOSD in particular in CD15+ cells (i.e., neutrophils and eosinophils). This study identifies a set of miRNAs in whole blood, which may have the potential to discriminate NMOSD from CIS/RRMS and healthy controls. In contrast, miRNA profiles in serum do not appear to be promising diagnostic biomarkers for NMOSD. Enrichment of altered miRNAs in CD15+ neutrophils and eosinophils, which were previously implicated in the pathophysiology of NMOSD, suggests that miRNAs could be involved in the regulation of these cells in NMOSD.
- 31 October 2015
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 12 (1) , 1-12
Open AccessNext-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis
Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) have a similar clinical phenotype but represent distinct diseases, requiring different therapies. MicroRNAs (miRNAs) are short non-coding RNAs whose expression profiles can serve as diagnostic biomarkers and which may be involved in the pathophysiology of neuroinflammatory diseases. Here, we analyzed miRNA profiles in serum and whole blood of patients with NMOSD and clinically isolated syndrome (CIS)/relapsing-remitting MS (RRMS) as well as healthy controls by next-generation sequencing (NGS). MiRNA expression profiles were determined by NGS in sera of patients with aquaporin-4 antibody-positive NMOSD (n = 20), CIS/RRMS (n = 20), and healthy controls (n = 20) and in whole blood of patients with NMOSD (n = 11), CIS/RRMS (n = 60), and healthy controls (n = 43). Differentially expressed miRNAs were calculated by analysis of variance and t tests. All significance values were corrected for multiple testing. Selected miRNAs were validated in whole blood of patients with NMOSD (n = 18) and CIS/RRMS (n = 19) by quantitative real-time polymerase chain reaction (qRT-PCR). None of 261 miRNAs detected in serum but 178 of 416 miRNAs detected in whole blood showed significantly different expression levels among the three groups. Pairwise comparisons revealed 115 (NMOSD vs. CIS/RRMS), 141 (NMOSD vs. healthy controls), and 44 (CIS/RRMS vs. healthy controls) miRNAs in whole blood with significantly different expression levels. qRT-PCR confirmed different expression levels in whole blood of patients with NMOSD and CIS/RRMS for 9 out of 10 exemplarily chosen miRNAs. In silico enrichment analysis demonstrated an accumulation of altered miRNAs in NMOSD in particular in CD15+ cells (i.e., neutrophils and eosinophils). This study identifies a set of miRNAs in whole blood, which may have the potential to discriminate NMOSD from CIS/RRMS and healthy controls. In contrast, miRNA profiles in serum do not appear to be promising diagnostic biomarkers for NMOSD. Enrichment of altered miRNAs in CD15+ neutrophils and eosinophils, which were previously implicated in the pathophysiology of NMOSD, suggests that miRNAs could be involved in the regulation of these cells in NMOSD.